Impact of complete surgical staging on survival of patients with early-stage (FIGO I or II) ovarian cancer: Data from the Cote d'Or Registry of Gynecological Cancers from 1998 to 2015.
Fiche publication
Date publication
février 2023
Journal
Bulletin du cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr ARNOULD Laurent, Dr DABAKUYO-YONLI Sandrine, Dr FAVIER Laure, Dr BENGRINE-LEFEVRE Leila, Dr FUMET Jean-David, Dr MAMGUEM KAMGA Ariane
Tous les auteurs :
Michel E, Mamguem Kamga A, Amet A, Padeano MM, Fumet JD, Favier L, Bengrine Lefevre L, Beltjens F, Arnould L, Dabakuyo S, Costaz H
Lien Pubmed
Résumé
Early-stage ovarian cancer represents 20 to 33% of all ovarian cancers and is thus quite rare in France, with around 1200 new cases per year. No study to date has convincingly demonstrated the utility of lymphadenectomy in early-stage ovarian cancer. We sought to evaluate the impact on overall survival of complete surgical staging in patients management for FIGO stage I and II ovarian cancer.
Mots clés
Early stage, Lymphadenectomy, Ovarian Cancer, Surgery
Référence
Bull Cancer. 2023 02 17;: